NexImmune Inc (NEXI)
3.37
-0.04
(-1.17%)
USD |
NASDAQ |
Apr 26, 16:00
3.42
+0.05
(+1.48%)
After-Hours: 20:00
NexImmune Shareholders Equity (Quarterly): 3.510M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.510M |
| September 30, 2023 | 8.254M |
| June 30, 2023 | 17.00M |
| March 31, 2023 | 23.58M |
| December 31, 2022 | 32.30M |
| September 30, 2022 | 47.72M |
| June 30, 2022 | 55.85M |
| March 31, 2022 | 70.39M |
| Date | Value |
|---|---|
| December 31, 2021 | 83.76M |
| September 30, 2021 | 97.11M |
| June 30, 2021 | 109.91M |
| March 31, 2021 | 120.46M |
| December 31, 2020 | -15.75M |
| September 30, 2020 | -9.234M |
| December 31, 2019 | 10.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-15.75M
Minimum
Dec 2020
120.46M
Maximum
Mar 2021
43.70M
Average
32.30M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Revelation Biosciences Inc | 6.648M |
| Spectral AI Inc | 1.456M |
| Corbus Pharmaceuticals Holdings Inc | -6.905M |
| Processa Pharmaceuticals Inc | 4.989M |
| Ensysce Biosciences Inc | -0.3229M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.594M |
| Total Liabilities (Quarterly) | 5.084M |